发明名称 1,2,4-triazine-4-amine derivatives
摘要 According to the invention there is provided a compound of formula A1 which may be useful in the treatment of a condition or disorder ameliorated by the inhibition of the A- A or, particularly, the A receptor wherein the compound of formula A1 has the structure, wherein, A represents Cy or Het; Cy represents a 5- to 14-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one, two or three rings, which Cy group is optionally substituted by one or more R substituents; Het represents a 5- to 14-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one, two or three rings and which HetA group is optionally substituted by one or more R4b substituents; B represents a Cy or Het; Cy represents a 3- to 10-membered aromatic, fully saturated or partially unsaturated carbocyclic ring system comprising one or two rings, which Cy group is optionally substituted by one or more R substituents; Het represents a 3- to 10-membered heterocyclic group that may be aromatic, fully saturated or partially unsaturated, and which contains one or more heteroatoms selected from O, S and N, which heterocyclic group may comprise one or two rings and which Het group is optionally substituted by one or more R substituents.
申请公布号 AU2011212430(A1) 申请公布日期 2012.08.23
申请号 AU20110212430 申请日期 2011.02.07
申请人 HEPTARES THERAPEUTICS LIMITED 发明人 CONGREVE, MILES STUART;ANDREWS, STEPHEN PHILIPPE;MASON, JONATHAN STEPHEN;RICHARDSON, CHRISTINE MARY;BROWN, GILES ALBERT
分类号 C07D253/07;A61K31/53;C07D401/04;C07D401/12;C07D401/14;C07D403/04;C07D403/12;C07D405/04;C07D405/10;C07D413/04;C07D417/12;C07D487/04 主分类号 C07D253/07
代理机构 代理人
主权项
地址